On September 15, 2025, in Secaucus, New Jersey, Quest Diagnostics Incorporated, a prominent player in diagnostic information services listed on NYSE as DGX, revealed that Sam Samad, the Executive Vice President and Chief Financial Officer, is set to discuss the company's strategy and performance. This announcement is part of an event where important insights will be shared with stakeholders.